Evidence map›Paper›PMID 27605453›Full record

ArticleAmerican journal of physiology. Cell physiology2016

Deficiency of the intermediate filament synemin reduces bone mass in vivo.

Megan C Moorer, Atum M Buo, Karla P Garcia-Pelagio, Joseph P Stains, Robert J Bloch

Abstract read
In one paragraph

Article in American journal of physiology. Cell physiology, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
2.5field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 19 citations in OpenAlex.

  1. Advanced Piezoelectric Materials, Devices, and Systems for Orthopedic Medicine.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2025
    Review
  2. Review
  3. Review
  4. Review
  5. Synemin Redefined: Multiple Binding Partners Results in Multifunctionality.Frontiers in cell and developmental biology · 2020
    Review
  6. Review
  7. Diminished Canonical β-Catenin Signaling During Osteoblast Differentiation Contributes to Osteopenia in Progeria.Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research · 2018
    Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Connexin43 and Runx2 Interact to Affect Cortical Bone Geometry, Skeletal Development, and Osteoblast and Osteoclast Function.Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research · 2017
    Article
  13. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Megan C MoorerDepartment of Orthopaedics, University of Maryland School of Medicine, Baltimore, Maryland; and.
Atum M BuoDepartment of Orthopaedics, University of Maryland School of Medicine, Baltimore, Maryland; and.
Karla P Garcia-PelagioDepartment of Physiology, University of Maryland School of Medicine, Baltimore, Maryland.
Joseph P StainsDepartment of Orthopaedics, University of Maryland School of Medicine, Baltimore, Maryland; and jstains@som.umaryland.edu.
Robert J BlochDepartment of Physiology, University of Maryland School of Medicine, Baltimore, Maryland.
University of Maryland, Baltimore · US

Funding

Intermediate Filaments & Costamere Structure & FunctionR01AR055928 · NIAMS · UNIVERSITY OF MARYLAND BALTIMORE · PI BLOCH, ROBERT J · 2009 to 2010
$758k
NIAMS NIH HHS R01 AR055928
6 · The paper itself

Abstract

While the type IV intermediate filament protein, synemin, has been shown to play a role in striated muscle and neuronal tissue, its presence and function have not been described in skeletal tissue. Here, we report that genetic ablation of synemin in 14-wk-old male mice results in osteopenia that includes a more than 2-fold reduction in the trabecular bone fraction in the distal femur and a reduction in the cross-sectional area at the femoral middiaphysis due to an attendant reduction in both the periosteal and endosteal perimeter. Analysis of serum markers of bone formation and static histomorphometry revealed a statistically significant defect in osteoblast activity and osteoblast number in vivo. Interestingly, primary osteoblasts isolated from synemin-null mice demonstrate markedly enhanced osteogenic capacity with a concomitant reduction in cyclin D1 mRNA expression, which may explain the loss of osteoblast number observed in vivo. In total, these data suggest an important, previously unknown role for synemin in bone physiology.

Indexed as

AnimalsBiomarkersBone DensityBone Diseases, MetabolicCancellous BoneCell DifferentiationCyclin D1FemurIntermediate Filament ProteinsIntermediate FilamentsMaleMiceMice, Inbred C57BLMice, KnockoutMuscle, SkeletalOsteoblastsBiomarkersCyclin D1desmuslinIntermediate Filament ProteinsRNA, MessengerAKAPcortical boneintermediate filamentosteoblastssynemintrabecular bone

Identifiers

PMID27605453
PMCPMC5206296
OpenAlexW2508931099

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.